ValueAct Surges as the Hedge Fund Benefits From Fox Battle

The activist hedge fund firm has seen big gains from its positions in 21st Century Fox and Valeant Pharmaceuticals.

Twenty-First Century Fox headquarters, New York (Alexander F. Yuan/Bloomberg)

Twenty-First Century Fox headquarters, New York

(Alexander F. Yuan/Bloomberg)

The battle between Walt Disney Co. and Comcast Corp. to buy assets from 21st Century Fox and Sky has been lucrative for Fox investors. And one of them is ValueAct Capital.

The San Francisco-based hedge fund firm is one of the top-performing activists this year thanks in part to the surge in Fox’s shares since the bidding war for some of its assets began last month.

To continue reading, subscribe now to Premium Journalism. Already a subscriber? login.

Related